Intra-Cellular Therapies Inc (MEX:ITCI)
MXN 1529.77 0 (0%) Market Cap: 183.55 Bil Enterprise Value: 163.69 Bil PE Ratio: 0 PB Ratio: 8.01 GF Score: 38/100

Q2 2021 Intra-Cellular Therapies Inc Earnings Call Transcript

Aug 09, 2021 / 12:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Intra-Cellular Therapies Second Quarter 2021 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your host today, Juan Sanchez, VP of Corporate Communications and Investor Relations. Please go ahead.

Juan Fernando Sanchez
Intra-Cellular Therapies, Inc. - VP of Corporate Communications & IR

Good morning, and thank you all for joining us for today's conference call. Our earnings press release provides a corporate update and details of the company's financial results for the second quarter ended June 30, 2021. This press release crossed the wire a short time ago and is available on our website at intracellulartherapies.com.

Joining me on the call today are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Neumann, Executive Vice President and Chief Commercial Officer; Dr. Suresh Durgam, Senior Vice President and Chief Medical Officer; and Larry

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot